Hyperkalemia in predialysis patients

Clinical Journal of the American Society of Nephrology

Volumn 7, Issue 8, 2012, Pages 1201-1202

  Palmer, Biff F ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; POTASSIUM; UREA;

BICARBONATE BLOOD LEVEL; CHRONIC KIDNEY DISEASE; DIALYSIS; ECHINACEA PURPUREA; EDITORIAL; GLOMERULUS FILTRATION RATE; HOMEOSTASIS; HUMAN; HYPERKALEMIA; KIDNEY FUNCTION; POTASSIUM BLOOD LEVEL; POTASSIUM HOMEOSTASIS; UREA BLOOD LEVEL;

FEMALE; HUMANS; HYPERKALEMIA; MALE; POTASSIUM; RENAL INSUFFICIENCY, CHRONIC;

EID: 84864827084     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.06060612     Document Type: Editorial

References (13)

1. Levy Yeyati N, Fellet A, Arranz C, Balaszczuk AM, Adrogué HJ: Amiloride-sensitive and amiloride-insensitive kaliuresis in advanced chronic kidney disease. J Nephrol 21: 93-98, 2008
2. Palmer BF: A physiologic-based approach to the evaluation of a patient with hyperkalemia. Am J Kidney Dis 56: 387-393, 2010
3. Sarafidis PA, Blacklock R, Wood E, Rumjon A, Simmonds S, Fletcher-Rogers J, AriyanayagamR, Al-Yassin A, Sharpe C, Vinen K: Prevalence and factors associated with hyperkalemia in predialysis patients followed in a low-clearance clinic. Clin J Am Soc Nephrol 7: 1234-1241, 2012
4. CoxBD, WhichelowMJ, PrevostAT: Seasonal consumption of salad vegetables and fresh fruit in relation to the development of cardiovascular disease and cancer. Public Health Nutr 3: 19-29, 2000
5. Sinclair D, Briston P, Young R, Pepin N: Seasonal pseudohyperkalaemia. J Clin Pathol 56: 385-388, 2003
6. Michelis MF: Hyperkalemia in the elderly. Am J Kidney Dis 16: 296-299, 1990
7. Hou FF, Zhang X, ZhangGH, XieD, Chen PY, ZhangWR, Jiang JP, Liang M, Wang GB, Liu ZR, Geng RW: Efficacy and safety of benazepril for advanced chronic renal insufficiency. NEngl JMed 354: 131-140, 2006
8. Palmer BF:Managing hyperkalemia caused by inhibitors of the reninangiotensin-aldosterone system. N Engl J Med 351: 585-592, 2004
9. RaebelMA, McClureDL, Simon SR, Chan KA, FeldsteinA, Andrade SE, Lafata JE, Roblin D, Davis RL, Gunter MJ, Platt R: Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers. Pharmacoepidemiol Drug Saf 16: 55-64, 2007
10. Moore CR, Lin JJ, O'Connor N, Halm EA: Follow-up of markedly elevated serum potassium results in the ambulatory setting: Implications for patient safety. Am J Med Qual 21: 115-124, 2006
11. Freeman K, Feldman JA, Mitchell P, Donovan J, Dyer KS, Eliseo L, White LF, Temin ES: Effects of presentation and electrocardiogram on time to treatment of hyperkalemia. Acad Emerg Med 15: 239-249, 2008
12. Einhorn LM, Zhan M, Hsu VD, Walker LD, Moen MF, Seliger SL, Weir MR, Fink JC: The frequency of hyperkalemia and its significance in chronic kidney disease. Arch Intern Med 169: 1156-1162, 2009
13. Montague BT, Ouellette JR, Buller GK: Retrospective review of the frequency of ECG changes in hyperkalemia. Clin J Am Soc Nephrol 3: 324-330, 2008